Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Saltigoto focus more on business opportunities in India - The Pharma Times | Pharma & Health Care News Portal

Saltigoto focus more on business opportunities in India

LANXESS subsidiary showcases solutions at Chemspec India

Mumbai, April 26, 2018: Saltigo GmbH, a subsidiary of specialty chemicals company LANXESS, will be presenting its comprehensive expertise and longstanding experience as a reliable custom manufacturing service provider and producer of multi-customer products at Chemspec India 2018, which is being held in Mumbai from April 25 to 26. “Saltigo has been participating in Chemspec India since 2010 and our presence here this year, too, only showcases our absolute confidence in the market potential that the Indian market has. We are aligned with our business targets and are working towards expanding our activities in the pharmaceutical and agrochemical segments. We look forward to strengthening our business with selected multi-customer products. We have also been successful in attracting customers from the specialty chemicals segment, where outsourcing is not yet a common practice, to our portfolio,” says TorstenDerr, Managing Director of Saltigo, summarizing the company’s plans.

Combining an exhibition and conferences, this tradeshow is an important event in India offering buyers and sellers of high-quality chemicals, based on complex synthesis requirements, the opportunity to further develop business partnerships and to initiate new business. “Our participation underlines the value we place on this important market and presents our company as a reliable supplier of chemical intermediates and partner for custom synthesis manufacturing with an efficient project management. Saltigo is a problem solver capable of shortening time to market, which is nowadays an important differentiation factor in the chemical industry.” says Christoph Schaffrath, Head of Key Account Management at Saltigo.

While in the past, India has been seen as a target for procurement and sourcing, the country is nowadays also a rapidly expanding market in the field of fine chemicals and active ingredients for pharmaceutical and crop protection applications. “We can support growth in custom manufacturing in particular, as this is our core competence,” says Dirk Sandri, Head of Sales at Saltigo. Key areas of expertise here include phosgenation and halogenation – such as reactions involving hydrogen fluoride or phosphorus chlorides and the Halex reaction. Further examples are metal organic syntheses, e.g. by means of a Grignard reaction, which is run at Saltigo in a multi-1000 ton-scale including the production of the reagent.

Saltigo keen to unlock new customer sectors

“Also for our multi-customer products such as phosgene derivatives or 1,2,4-triazole, India is an important market. In addition, we strive for business with innovative companies specializing in photovoltaics, polymers, lubricants, flavor and fragrances and biocides,” he adds.

In addition, Saltigo is awaiting the registration of its insect repellent Saltidin (chemical name Icaridin) in India. Insect repellents containing the active ingredient of Saltigo protect against infection with dangerous diseases, like the Zika virus or dengue fever, by keeping mosquitoes at bay. Saltigo has reacted fast to the increased demand by increasing the production capacity significantly  and has taken measures for additional capacity expansion.

Saltigo supplies products to some 150 customers from the agrochemical, pharmaceutical and fine chemicals industries. These include active ingredients and intermediates for crop protection agents and medicines together with chemicals for numerous applications, such as the tried-and-tested insect repellent active ingredient Saltidin.

Saltigo offers manufacturing opportunities based on complex chemistry and technology needs having passed an FDA-audit. The extensive know-how in implementing technical customer requirements and developing and optimizing custom-made processes in extremely well structured chemical parks in Leverkusen and Dormagen is one of the reasons why high-profile companies in many countries around the world choose the LANXESS subsidiary, Saltigo, as a full-service supplier which shows a high commitment to quality, safety and environmental protection.

Detailed information about Saltigo’s services can be obtained online at www.saltigo.com.

Saltigo GmbH is a leading supplier in the field of custom synthesis. The company of specialty chemicals group LANXESS belongs to the Advanced Intermediates segment, which achieved total sales in 2012 of EUR 1,647million. Saltigo, headquartered in Leverkusen and with production facilities in Leverkusen and Dormagen, employs around 1,200 staff worldwide.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

3 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

5 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago